U.S. Markets closed

MEDNAX, Inc. (MD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
20.44+0.10 (+0.49%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.34
Open20.34
Bid20.37 x 800
Ask20.39 x 800
Day's Range20.06 - 20.53
52 Week Range7.37 - 28.66
Volume517,927
Avg. Volume1,172,889
Market Cap1.747B
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y
    Zacks

    MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y

    MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

  • Mednax Inc (MD) Q2 2020 Earnings Call Transcript
    Motley Fool

    Mednax Inc (MD) Q2 2020 Earnings Call Transcript

    Joining me today for our call are our Chief Executive Officer, Mark Ordan; our Chief Financial Officer, Stephen Farber; and President of Pediatrics and Obstetrics Medical Group, Dr. Mack Hinson. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.

  • Benzinga

    Recap: Mednax Q2 Earnings

    Shares of Mednax (NYSE:MD) were flat in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 64.04% over the past year to $0.32, which may not compare to the estimate of $0.09.Revenue of $509,203,000 declined by 41.36% year over year, which missed the estimate of $555,920,000.Outlook Earnings guidance hasn't been issued by the company for now.Mednax hasn't issued any revenue guidance for the time being.Details Of The Call Date: Jul 30, 2020View more earnings on MDTime: 10:00 AMET Webcast URL: https://edge.media-server.com/mmc/p/4u5r53dbTechnicals 52-week high: $28.66Company's 52-week low was at $7.37Price action over last quarter: Up 38.44%Company Profile Mednax provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. Mednax generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.See more from Benzinga * Earnings Scheduled For July 30, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.